Carfilzomib weekly 20/56 mg/m2, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma

American Journal of Hematology, EarlyView.

Source: American Journal of Hematology - November 25, 2018 Category: Hematology Authors: Valentine Richez, Cecile Gruchet, Stephanie Guidez, Guillemette Fouquet, Isabelle Azais, Geraldine Durand, Vincent Javaugue, Antoine Brigaud, Florent Plasse, J éremie Diolez, Antoine Machet, Niels Moya, Helene Gardeney, Paul Franques, Arthu Tags: CORRESPONDENCE Source Type: research